Zimmer Biomet Holdings

Courtesy of Zimmer Biomet Holdings
  • Previous Rank
    431
  • Revenues ($M)
    7684
  • Revenue Percent Change
    28.1
  • Profits ($M)
    305.9
  • Profits Percent Change
    108.1
  • Assets ($M)
    26684
  • Employees
    18500
  • Market Value — as of March 31, 2017 ($M)
    24571

The medical device company sprung from the $14 billion mega merger between two orthopedic powerhouses, Zimmer and Biomet, in 2015. Since then, the company has seen its CEO resign abruptly and as of July 2017, it seemed to struggle meeting financial projections.

Company Info

CEODaniel P. Florin
CEO TitleInterim Chief Executive Officer & Director
SectorHealth Care
IndustryMedical Products and Equipment
HQ LocationWarsaw, IN
Websitewww.zimmerbiomet.com
Years on Fortune 500 List2
Employees18,500

Key Financials (Last Fiscal Year)

Revenues ($M)$7,684
Profits ($M)$305.9
Assets ($M)$26,684
Total Stockholder Equity ($M)$9,669
Market Value — as of March 31, 2017 ($M)$24,571

Profit Ratios

Profit as % of Revenues4%
Profits as % of Assets1.1%
Profits as % of Stockholder Equity3.2%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)2
EPS % Change (from 2015)96.1%
EPS % Change (5 year annual rate)-17.8%
EPS % Change (10 year annual rate)-7.8%

Total Return

Total Return to Investors (2016)1.4%
Total Return to Investors (5 year, annualized)15.1%
Total Return to Investors (10 year, annualized)3.2%